Home » Topics » BioWorld Science

BioWorld Science
RSS

Novo Nordisk expands chronic disease focus beyond type 1 diabetes

May 17, 2018

Eleven Biotherapeutics changes name to Sesen Bio

May 17, 2018

European Commission approves Cabometyx for first-line treatment of advanced RCC

May 17, 2018

IDMC recommends continuation of enrollment in phase IIa study of milciclib in HCC

May 17, 2018

Eiger Biopharmaceuticals obtains rights to lonafarnib for Hutchinson-Gilford progeria syndrome

May 17, 2018

KalVista Pharmaceuticals develops new agents for diabetic retinopathy

May 17, 2018

First phase III clinical results presented for esketamine in treatment-resistant depression

May 17, 2018

FluGen's M2SR influenza vaccine begins challenge study

May 17, 2018

FDA grants rare pediatric disease designation to MYO-101 for limb girdle muscular dystrophy type 2E

May 17, 2018

FDA awards rare pediatric disease designation to CCP-020

May 17, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...